Distribution of uridine diphosphate glucuronosyltransferase 1A polymorphisms and their role in irinotecan‑induced toxicity in patients with cancer

Yang Wang(Shandong Normal University), Xiuwen Wang(Second Hospital of Shandong University), Bei Li(Harbin Medical University), Dan Wang(Tianjin University of Traditional Chinese Medicine), Jintong Du(Shandong Tumor Hospital), Hui Li(Shandong Tumor Hospital), Cuihua Yi(Qilu Hospital of Shandong University), Yawei Wang(Shenzhen Luohu People's Hospital), Lian Liu(Qilu Hospital of Shandong University)
Oncology Letters
September 14, 2017
10.3892/ol.2017.6933
Cited by 11

Related Papers

Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma
|JAMA|2021|821
Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial
|BMJ|2022|494
Tumor Necrosis Factor α-induced Phosphorylation of RelA/p65 on Ser529 Is Controlled by Casein Kinase II
|Journal of Biological Chemistry|2000|450
Activation of Nuclear Factor-κB-dependent Transcription by Tumor Necrosis Factor-α Is Mediated through Phosphorylation of RelA/p65 on Serine 529
|Journal of Biological Chemistry|1998|379
Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus–related hepatocellular carcinoma
|Nature Genetics|2012|322